174 related articles for article (PubMed ID: 9085489)
1. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.
Earley CJ; Allen RP
Sleep; 1996 Dec; 19(10):801-10. PubMed ID: 9085489
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of the restless legs syndrome with carbidopa/levodopa.
Allen RP; Earley CJ
Sleep; 1996 Apr; 19(3):205-13. PubMed ID: 8723377
[TBL] [Abstract][Full Text] [Related]
3. Treatment of restless leg syndrome with pergolide--an open clinical trial.
Winkelmann J; Wetter TC; Stiasny K; Oertel WH; Trenkwalder C
Mov Disord; 1998 May; 13(3):566-9. PubMed ID: 9613756
[TBL] [Abstract][Full Text] [Related]
4. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
Staedt J; Wassmuth F; Ziemann U; Hajak G; Rüther E; Stoppe G
J Neural Transm (Vienna); 1997; 104(4-5):461-8. PubMed ID: 9295178
[TBL] [Abstract][Full Text] [Related]
5. Entacapone prolongs the reduction of PLM by levodopa/carbidopa in restless legs syndrome.
Polo O; Ylä-Sahra R; Hirvonen K; Karvinen J; Vahteristo M; Ellmén J
Clin Neuropharmacol; 2007; 30(6):335-44. PubMed ID: 18090458
[TBL] [Abstract][Full Text] [Related]
6. Effect of pergolide on restless legs and leg movements in sleep in uremic patients.
Pieta J; Millar T; Zacharias J; Fine A; Kryger M
Sleep; 1998 Sep; 21(6):617-22. PubMed ID: 9779521
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mortality in pergolide-treated patients with Parkinson's disease.
Sayler ME; Street JS; Bosomworth JC; Potvin JH; Kotsanos JG
Neuroepidemiology; 1996; 15(1):26-32. PubMed ID: 8719046
[TBL] [Abstract][Full Text] [Related]
8. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep.
Santamaria J; Iranzo A; Tolosa E
Sleep Med; 2003 Mar; 4(2):153-5. PubMed ID: 14592347
[TBL] [Abstract][Full Text] [Related]
9. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.
Kaplan PW; Allen RP; Buchholz DW; Walters JK
Sleep; 1993 Dec; 16(8):717-23. PubMed ID: 8165385
[TBL] [Abstract][Full Text] [Related]
11. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
[TBL] [Abstract][Full Text] [Related]
12. Entacapone in restless legs syndrome.
Sharif AA
Mov Disord; 2002 Mar; 17(2):421. PubMed ID: 11921139
[TBL] [Abstract][Full Text] [Related]
13. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
Olanow CW; Alberts MJ
Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
[No Abstract] [Full Text] [Related]
14. Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen.
Brown LK; Heffner JE; Obbens EA
Sleep; 2000 Aug; 23(5):591-4. PubMed ID: 10947026
[TBL] [Abstract][Full Text] [Related]
15. L-DOPA/carbidopa for nocturnal movement disorders in uremia.
Walker SL; Fine A; Kryger MH
Sleep; 1996 Apr; 19(3):214-8. PubMed ID: 8723378
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide).
Ahlskog JE; Muenter MD; Bailey PA; Stevens PM
Arch Neurol; 1992 May; 49(5):560-8. PubMed ID: 1580821
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
Razazian N; Azimi H; Heidarnejadian J; Afshari D; Ghadami MR
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):271-8. PubMed ID: 25758874
[TBL] [Abstract][Full Text] [Related]
18. I couldn't sleep at all last night.
Young DK
J Clin Sleep Med; 2005 Jan; 1(1):95-6. PubMed ID: 17561620
[No Abstract] [Full Text] [Related]
19. L-dopa in uremic patients with the restless legs syndrome.
Sandyk R; Bernick C; Lee SM; Stern LZ; Iacono RP; Bamford CR
Int J Neurosci; 1987 Aug; 35(3-4):233-5. PubMed ID: 3654080
[TBL] [Abstract][Full Text] [Related]
20. [Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone].
Kulua TK; Fedorova NV; Popovkina OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):45-50. PubMed ID: 22027607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
